Redefining API Excellence.
Globally Compliant. Trusted Worldwide
Your reliable partner for APIs
Innovative and Integrated
API
Solutions
Our API portfolio primarily comprises low-volume, high-value niche molecules in therapeutic areas like CNS, Urology, Coagulation amongst others. We are continuously expanding our portfolio, addressing evolving market and customer needs.
Our API Portfolio
All our APIs are developed and manufactured with robust process development, advanced analytical capabilities, and with strict adherence to international regulatory standards and intellectual property rights, ensuring reliable supply to regulated global markets.
As part of lifecycle management we focus on continuous improvement to enhance cost efficiency for our customers. While implementing improvements, our R&D team ensures minimal impact on existing regulatory filings, facilitating a smooth and compliant transition to improved processes without affecting product registration or market supply.
| DMF to be filed
| IHS- In-house Specs
| Products | Quality Std. | Indication | Regulatory Status | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ambrisentan | IHS / IP | Pulmonary hypertension | |||||||||||
| Apixaban | IHS | Coagulation | |||||||||||
| Apremilast | IHS / IP | Psoriatic Arthritis | |||||||||||
| Asenapine Maleate | IHS / IP | Schizophrenia | |||||||||||
| Bosentan Monohydrate | IHS / IP | Pulmonary hypertension | |||||||||||
| Cinacalcet HCl | IHS / IP | Hyperparathyroidism | |||||||||||
| Dabigatran Etexilate Mesylate | Ph. Eur / IHS | Coagulation | |||||||||||
| Darifenacin HBr | IHS / IP | Overactive Bladder | |||||||||||
| Desvenlafaxine Succinate | IHS / USP | Depression | |||||||||||
| Donepezil HCl Form I | USP / Ph. Eur / IP | Alzheimer's | |||||||||||
| Donepezil HCl Form III | USP / Ph. Eur / JP / IP | Alzheimer's | |||||||||||
| Edoxaban Tosylate | IHS | Coagulation | |||||||||||
| Lurasidone HCl | IHS | Schizophrenia | |||||||||||
| Memantine HCl | USP / IHS / Ph.Eur. | Alzheimer's | |||||||||||
| Mirabegron | IHS / Ph.Eur. | Overactive Bladder | |||||||||||
| Mirtazapine Anhydrous | USP / Ph.Eur / IP | Depression | |||||||||||
| Mirtazapine Hemihydrate | USP / Ph.Eur / IP | Depression | |||||||||||
| Paliperidone | IHS / USP / IP | Schizophrenia | |||||||||||
| Prasugrel HCl | USP / Ph.Eur. / IP | Thrombosis | |||||||||||
| Quetiapine Hemifumarate | USP / Ph.Eur / IP | Schizophrenia | |||||||||||
| Rivaroxaban | Ph. Eur / USP | Coagulation | |||||||||||
| Solifenacin Succinate | Ph. Eur / IHS / IP | Overactive Bladder | |||||||||||
| Teriflunomide | Ph. Eur / IHS | Multiple sclerosis | |||||||||||
| Venlafaxine HCl | USP / Ph.Eur / IP | Depression | |||||||||||
| Vildagliptin | IHS / IP | Diabetes | |||||||||||
| Vortioxetine HBr | IHS | Depression | |||||||||||
| Ziprasidone HCl | USP / Ph.Eur / IP | Schizophrenia | |||||||||||
| DMF to be filed
| IHS- In-house Specs
| Products | Quality Std. | Indication | Regulatory Status | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morantel Citrate | IHS | Anthelmintic | |||||||||||
| Morantel Tartrate | USP / Ph.Eur / BP | Anthelmintic | |||||||||||
| Oxantel Pamoate | IHS | Anthelmintic | |||||||||||
| Pyrantel Pamoate / Embonate | USP / Ph.Eur / JP / IP | Anthelmintic | |||||||||||
| Pyrantel Tartrate | IHS | Anthelmintic | |||||||||||
| DMF to be filed
| IHS- In-house Specs
| Products | Quality Std. | Indication | Regulatory Status | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cariprazine HCl | IHS | Schizophrenia | |||||||||||
| Fezolinetant | IHS | Vasomotor Symptoms | |||||||||||
| Finerenone | IHS | Chronic Kidney Disease | |||||||||||
| Resmetirom | IHS | NASH | |||||||||||
| Vericiguat | IHS | Heart Failure (HFrEF) | |||||||||||
| Vibegron | IHS | Overactive Bladder | |||||||||||
| Xanomeline Tartrate | IHS | Schizophrenia | |||||||||||
| DMF to be filed
| IHS In-house Specs
| Products | Quality Std. | Indication | Regulatory Status | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ambrisentan | IHS / IP | Pulmonary hypertension | |||||||||||
| Apixaban | IHS | Coagulation | |||||||||||
| Apremilast | IHS / IP | Psoriatic Arthritis | |||||||||||
| Asenapine Maleate | IHS / IP | Schizophrenia | |||||||||||
| Bosentan Monohydrate | IHS / IP | Pulmonary hypertension | |||||||||||
| Cinacalcet HCl | IHS / IP | Hyperparathyroidism | |||||||||||
| Darifenacin HBr | IHS / IP | Overactive Bladder | |||||||||||
| Desvenlafaxine Succinate | IHS / USP | Depression | |||||||||||
| Donepezil HCl Form I | USP / Ph. Eur / IP | Alzheimer's | |||||||||||
| Donepezil HCl Form III | USP / Ph. Eur / JP / IP | Alzheimer's | |||||||||||
| Edoxaban Tosylate | IHS | Coagulation | |||||||||||
| Lurasidone HCl | IHS | Schizophrenia | |||||||||||
| Memantine HCl | USP / IHS / Ph.Eur. | Alzheimer's | |||||||||||
| Mirabegron | IHS / Ph.Eur. | Overactive Bladder | |||||||||||
| Mirtazapine Anhydrous | USP / Ph.Eur / IP | Depression | |||||||||||
| Mirtazapine Hemihydrate | USP / Ph.Eur / IP | Depression | |||||||||||
| Quetiapine Hemifumarate | USP / Ph.Eur / IP | Schizophrenia | |||||||||||
| Rivaroxaban | Ph. Eur / USP | Coagulation | |||||||||||
| Solifenacin Succinate | Ph. Eur / IHS / IP | Overactive Bladder | |||||||||||
| Teriflunomide | Ph. Eur / IHS | Multiple Sclerosis | |||||||||||
| Venlafaxine HCl | USP / Ph.Eur / IP | Depression | |||||||||||
| Vildagliptin | IHS / IP | Diabetes | |||||||||||
| Vortioxetine HBr | IHS | Depression | |||||||||||
| Ziprasidone HCl | USP / Ph.Eur / IP | Schizophrenia | |||||||||||
| DMF to be filed
| IHS In-house Specs
| Products | Quality Std. | Indication | Regulatory Status | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morantel Citrate | IHS | Anthelmintic | |||||||||||
| Morantel Tartrate | USP / Ph.Eur / BP | Anthelmintic | |||||||||||
| Oxantel Pamoate | IHS | Anthelmintic | |||||||||||
| Pyrantel Pamoate / Embonate | USP / Ph.Eur / JP / IP | Anthelmintic | |||||||||||
| Pyrantel Tartrate | IHS | Anthelmintic | |||||||||||
| Products | Quality Std. | Indication |
|---|---|---|
| Cariprazine HCl | IHS | Schizophrenia |
| Fezolinetant | IHS | Vasomotor Symptoms |
| Finerenone | IHS | Chronic Kidney Disease |
| Resmetirom | IHS | NASH |
| Vericiguat | IHS | Heart Failure (HFrEF) |
| Vibegron | IHS | Overactive Bladder |
| Xanomeline Tartrate | IHS | Schizophrenia |
Our Chemistry
Regulatory Approvals